Erigeron breviscapus dispersion tablet
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ηζ΅·η
- Publication Date
- 2005-03-23
- Estimated Expiration
- Not applicable Β· inactive patent
Abstract
Description
technical field
[0001] The invention relates to a breviscapine dispersible tablet for treating cardiovascular and cerebrovascular diseases, and belongs to the technical field of traditional Chinese medicines. Background technique
[0002] Pharmacological studies have shown that breviscapine has the functions of enhancing cerebral blood flow, inhibiting thrombus formation, inhibiting abnormal lipoprotein metabolism in patients with ischemic cerebrovascular disease, anti-myocardial ischemia, and enhancing myocardial nutritional blood volume. Significant curative effect. Existing breviscapine preparations have oral liquid, injection, common tablet, effervescent tablet, dripping pill in various forms, but are subject to certain restrictions in clinical use and promotion. Since breviscapine is a flavonoid component, its water solubility is very poor, so ordinary tablets, effervescent tablets and dripping pills have the problems of slow disintegration and slow dissolution, which ...